Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Niramas Utama Tbk. (JELI) vs Medco Energi Internasional Tbk. (MEDC) Price & Performance

Niramas Utama Tbk.Trade
Medco Energi Internasional Tbk.Trade

Price performance (Past 24H)

Key statistics

Niramas Utama Tbk. vs Medco Energi Internasional Tbk. — how do they compare? Niramas Utama Tbk. trades at Rp515 (market cap 670.98B, 3.31M 24h volume), while Medco Energi Internasional Tbk. trades at Rp1,555 (market cap 39.46T, 55.01M 24h volume). The key difference: Medco Energi Internasional Tbk. is far larger — about 58.8× Niramas Utama Tbk.'s market cap, and Medco Energi Internasional Tbk. is more actively traded (55.01M versus 3.31M). Which is the better fit depends on your goals.

JELIMEDC
Market Cap
670.98B39.46T
Volume
3.31M55.01M
Lot
33.07K550.06K
Turnover
1.71B87.49B
Average Price
516.61,590.64
Value
1.71B87.49B
Indicative Equilibrium Price
5151,555
Indicative Equilibrium Volume
68013.38K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JELI
View details
MEDC
View details

About Niramas Utama Tbk.

PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama

Read more on JELI

About Medco Energi Internasional Tbk.

PT Medco Energi Internasional Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970, based on notarial deed No. 19 of Imas Fatimah, S.H., dated June 9, 1980. Medco Energi Corporation is holding company for energy related business within the Medco Group of companies. On March 1997 the company cooperated with Myanmar Oil and Gas Enterprise plan to handle 8,000 m2 of suspended field in Myanmar. Company is a PMDN

Read more on MEDC